You have 9 free searches left this month | for more free features.

Condition

Colon Cancer (1)

Esophagus Adenocarcinoma (1)

Rectal Cancer (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Eli Lilly and Company (1)

Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)

Collaborator

Intervention

mfolfox-6 (2)

durvalumab (1)

flot (1)

icrucumab (1)

radiotherapy (1)

ramucirumab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

mfolfox-6

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting

Esophagus Adenocarcinoma

Durvalumab
+3 more

Frankfurt, Germany

Institute of Clinical Cancer Research, University Cancer Center

Jan 26, 2023

Colon Cancer, Rectal Cancer Trial in Canada, United States (Ramucirumab, Icrucumab, mFOLFOX-6)

Completed

Colon Cancer
Rectal Cancer

Ramucirumab
+2 more

Cincinnati, Ohio
+16 more

Jul 15, 2019